Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Market Cap
$19.77M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$19.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$22.00M
Net Profit Margin
-24.76%
TTM Avg
-22.59%
3Y Avg
-21.34%
5Y Avg
-47.79%
Market Cap
$22.25M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$18.65M
Net Profit Margin
-1578.40%
TTM Avg
-574.01%
3Y Avg
-287.00%
5Y Avg
-1306.57%
Market Cap
$18.41M
Net Profit Margin
-6.55%
TTM Avg
-9.60%
3Y Avg
-12.37%
5Y Avg
-13.41%
Market Cap
$18.30M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NextCure, Inc. (NXTC) | $20.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quantum BioPharma Ltd. (QNTM)vs › | $19.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | -24.76% | -22.59% | -21.34% | -47.79% |
| Modular Medical, Inc. (MODD)vs › | $22.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | -1578.40% | -574.01% | -287.00% | -1306.57% |
| P3 Health Partners Inc. (PIII)vs › | $18.41M | -6.55% | -9.60% | -12.37% | -13.41% |
| LeonaBio, Inc. (LONA)vs › | $22.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 43.49% |
| 2019-12-31 | -544.99% |
| 2019-09-30 | -532.79% |
| 2019-06-30 | -586.38% |
| 2019-03-31 | -453.57% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
